News

WASHINGTON (May 13, 2019) — The George Washington University (GW) Cancer Center is pleased to announce the establishment of the Dr. Cyrus Katzen Family Director of the GW Cancer Center, thanks to a generous gift from GW alumnus and former Board of Trustee member, Jay Katzen, BA ’67, MD ’72 . The...

WASHINGTON (April 30, 2019)—The George Washington University (GW) Cancer Center recently welcomed 12 multidisciplinary health care teams from across the U.S. and territories to its second TEAM (Together, Equitable, Accessible, Meaningful) Training program. The two-and-a-half day program was the...

WASHINGTON (March 27, 2019) – Principal Investigator Mandi Pratt-Chapman, MA has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention (CDC) to provide comprehensive technical assistance for National Comprehensive Cancer Control...

The George Washington University (GW) Cancer Center is pleased to announce that accomplished medical oncologist George Kim, MD, has joined the GW Cancer Center. He will serve as the director of the Gastrointestinal Cancers Program at the GW Cancer Center.

A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.

The George Washington University (GW) Cancer Center and the GW School of Medicine and Health Sciences (SMHS) will have a large presence at the upcoming American Academy of Dermatology Association (AAD) Annual Meeting. The meeting will be held at the Walter E. Washington Convention Center in...

A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).

The George Washington University (GW) Cancer Center is pleased to announce the expansion of the Cutaneous Oncology Multidisciplinary Program. The program will bring together dermatologists, dermatologic surgeons, medical, surgical and radiation oncologists, and pathologists to provide personalized skin cancer care to patients in the District and surrounding region.

A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.

The GW Cancer Center hosts a monthly breast cancer disparities work group to facilitate connections across the University between researchers, clinicians and members of the community, including survivors and caregivers.

WASHINGTON (Jan. 28, 2018) — A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer. The goal of this nanoimmunotherapy combination is to increase the potency of immune...

Members of the George Washington University (GW) Cancer Center, including Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity, recently published several journal articles and patient-focused pieces highlighting the GW Cancer Center’s work in patient navigation and survivorship.

The George Washington University (GW) Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS , an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology Program...

Cancer of the skin is by far the most common of all cancers with melanoma being the cause of the majority of skin cancer deaths. The incidence of melanoma continues to increase and it has become one of the most common forms of cancer in the United States, especially among young adult women ages 20-...

The George Washington University (GW) Cancer Center recently hosted Improving Care for Sexual and Gender Minorities: A Symposium for Health Care Professional Students and Faculty at the Elliott School of International Affairs.

Gazing at the iconic 19th-century Japanese woodcut known as “The Great Wave off Kanagawa,” one would hardly suspect it contains a key to a medical breakthrough. Yet the pigment in the artwork has opened a new perspective in the treatment of juvenile cancer.

Innumerable questions and concerns loom after a cancer diagnosis. Among them: Should I participate in a clinical trial, or should I stick with the standard of care? Here's an inside look at the clinical trials process.

A research team led by Catherine Bollard, PhD, associate center director for translational research and innovation, has developed a new therapeutic cancer treatment called TAA-T.

In June 2018, before a room full of oncology experts, Robert Siegel, MD ’77, associate center director for education, training, and network development at the GW Cancer Center, described a new treatment developed for patients suffering from oropharyngeal cancer.

The future of cancer research, in the opinion of Katherine Chiappinelli, PhD, of the GW School of Medicine and Health Sciences, revolves around combining immunotherapy with other treatments.

The George Washington University (GW) Cancer Center was pleased to participate in the 43rd Annual Marine Corps Marathon (MCM) on October 28, 2018. The event is one of the largest in the world with over 30,000 participants and brings together multiple organizations to raise funds for charitable...

Applications for the second cohort of the Together, Equitable, Accessible, Meaningful (TEAM) Training are now open! This no-cost training aims to support equitable, accessible and patient-centered cancer care. The training provides guidance, tools and resources to help individuals and organizations...

WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by the...

Associate Professor at the Milken Institute School of Public Health at GW and GW Cancer Center member Kim Robien, PhD, RD, CSO, FAND, received the Distinguished Practice Award from the Oncology Nutrition practice group of the Academy of Nutrition and Dietetics on October 21st at the annual Food and...

A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct. 17 to cut the ribbon on a new multi-disciplinary cancer clinical space in the ground floor of the GW Medical Faculty Associates (GW MFA) Ambulatory Care...